Kim, Hyein
Kwon, Seongae
Park, Sunyoung
Kang, Chaehyeon
Kim, Heejung https://orcid.org/0000-0003-3719-0111
Article History
Received: 22 November 2024
Accepted: 17 June 2025
First Online: 1 July 2025
Ethics approval and consent to participate
: The study was conducted in accordance with the guidelines of the Declaration of Helsinki and was approved by the Institutional Review Board of Yonsei University Health System (IRB No.4-2023-0096 on March 22, 2023). We assured that informed consent was obtained from all participants involved in the primary study (IRB No.4-2021-0219) for this secondary data analysis. In the primary study, the participants were invited to participate voluntarily and had their questions answered satisfactorily. They read and understood the explanation of the study’s purpose, methods, expected outcomes, potential risks, and health information management. Participants confirmed that they could withdraw from the study at any time without repercussion and agreed that the collected data could be used for future secondary research. They voluntarily consented to participate in the study.
: Not applicable.
: The authors declare that they have no competing interests.